Spindletop Health Acquisition Corp. (SHCAU) is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, with a focus on the healthcare services industry sector, including healthcare services, healthcare information technology, insurance and related products, biotechnology, pharmaceuticals, medical devices, and diagnostics. Incorporated on February 17, 2021, as a Delaware corporation and headquartered in Austin, Texas, the company has no significant current operations and generates no revenues. The company completed a $230 million initial public offering in November 2021, with units listed on Nasdaq under the ticker SHCAU, led by CEO and Director Dr. Evan S. Melrose, COO Dr. Kelly Huang, and Chairman James Henry. In a major development, Spindletop Health Acquisition Corp. announced its liquidation and dissolution in December 2022 after failing to identify a suitable acquisition target by the board-set termination date of December 20, 2022, opting not to implement a stockholder-approved extension; public shares were redeemed by December 27, 2022. The company conducted its search primarily in the United States healthcare ecosystem but ceased operations without completing any mergers, partnerships, or strategic shifts.